Table 2 Summary of adverse events
Adverse events | SCCR (n = 20) | CCR (n = 20) |
|---|---|---|
G3/4 (≥G3) (%) | G3/4 (≥G3) (%) | |
Haematolgic | ||
Leukopenia | 4/1 (25.0%) | 3/1 (20.0%) |
Thrombocytopenia | 4/0 (20.0%) | 3/1 (20.0%) |
Neutropenia | 4/0 (20.0%) | 3/0 (15.0%) |
Febrile neutropenia | 3/0 (15.0%) | 3/0 (15.0%) |
Anaemia | 3/0 (15.0%) | 2/0 (10.0%) |
Non-haematolgic | ||
Anorexia | 3/0 (15.0%) | 2/0 (10.0%) |
Nausea | 1/1 (10.0%) | 2/0 (10.0%) |
Constipation | 2/0 (10.0%) | 2/0 (10.0%) |
Oesophagitis | 2/0 (10.0%) | 1/0 (5.0%) |
Fatigue | 1/0 (5.0%) | 2/0 (10.0%) |
ALT, AST | 1/0 (5.0%) | 0/0 (0%) |
Pneumonitis | 1/0 (5.0%) | 0/0 (0%) |
Diarrhoea | 0/0 (0%) | 1/0 (5.0%) |